PEAK PHARMACEUTICALS, INC. (RMHI) Operating income 2015–2022
PEAK PHARMACEUTICALS, INC. (RMHI) annual operating income history from SEC filings — each fiscal year as reported.
-$163,302FY2022 · since FY2015: -$2.3M → -$163,302
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$163,302 | -137.6% |
| FY2021 | -$68,721 | -1141.6% |
| FY2020 | -$5,535 | +2.6% |
| FY2019 | -$5,684 | +79.6% |
| FY2018 | -$27,823 | +38.2% |
| FY2017 | -$44,987 | -104.1% |
| FY2016 | $1.1M | +146.5% |
| FY2015 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice